≡

ELISA Kit for Fibroblast Growth Factor 9 (FGF9)

GAF; HBFG9; Glia-Activating Factor; Heparin-Binding Growth Factor 9

Specificity

This assay has high sensitivity and excellent specificity for detection of Fibroblast Growth Factor 9 (FGF9).
No significant cross-reactivity or interference between Fibroblast Growth Factor 9 (FGF9) and analogues was observed.

Recovery

Matrices listed below were spiked with certain level of recombinant Fibroblast Growth Factor 9 (FGF9) and the recovery rates were calculated by comparing the measured value to the expected amount of Fibroblast Growth Factor 9 (FGF9) in samples.

Matrix Recovery range (%) Average(%)
serum(n=5) 87-105 95
EDTA plasma(n=5) 95-102 98
heparin plasma(n=5) 93-101 97

Precision

Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Fibroblast Growth Factor 9 (FGF9) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Fibroblast Growth Factor 9 (FGF9) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%

Linearity

The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Fibroblast Growth Factor 9 (FGF9) and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.

Sample 1:2 1:4 1:8 1:16
serum(n=5) 88-95% 83-101% 79-96% 85-101%
EDTA plasma(n=5) 80-99% 92-103% 94-105% 97-105%
heparin plasma(n=5) 98-105% 87-97% 81-101% 95-104%

Stability

The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.

Reagents and materials provided

Reagents Quantity Reagents Quantity
Pre-coated, ready to use 96-well strip plate 1 Plate sealer for 96 wells 4
Standard 2 Standard Diluent 1×20mL
Detection Reagent A 1×120µL Assay Diluent A 1×12mL
Detection Reagent B 1×120µL Assay Diluent B 1×12mL
TMB Substrate 1×9mL Stop Solution 1×6mL
Wash Buffer (30 × concentrate) 1×20mL Instruction manual 1

Assay procedure summary

1. Prepare all reagents, samples and standards;
2. Add 100µL standard or sample to each well. Incubate 1 hours at 37°C;
3. Aspirate and add 100µL prepared Detection Reagent A. Incubate 1 hour at 37°C;
4. Aspirate and wash 3 times;
5. Add 100µL prepared Detection Reagent B. Incubate 30 minutes at 37°C;
6. Aspirate and wash 5 times;
7. Add 90µL Substrate Solution. Incubate 10-20 minutes at 37°C;
8. Add 50µL Stop Solution. Read at 450nm immediately.

GIVEAWAYS

INCREMENT SERVICES

Magazine Citations
Respiratory Research Resolution of bleomycin-induced murine pulmonary fibrosis via a splenic lymphocyte subpopulation Pubmed:29690905
Catalog No. Related products for research use of Bos taurus; Bovine (Cattle) Organism species Applications (RESEARCH USE ONLY!)
RPA036Bo01 Recombinant Fibroblast Growth Factor 9 (FGF9) Positive Control; Immunogen; SDS-PAGE; WB.
PAA036Bo01 Polyclonal Antibody to Fibroblast Growth Factor 9 (FGF9) WB; IHC; ICC; IP.
MAA036Bo21 Monoclonal Antibody to Fibroblast Growth Factor 9 (FGF9) WB; IHC; ICC; IP.
SEA036Bo ELISA Kit for Fibroblast Growth Factor 9 (FGF9) Enzyme-linked immunosorbent assay for Antigen Detection.
SCA036Bo CLIA Kit for Fibroblast Growth Factor 9 (FGF9) Chemiluminescent immunoassay for Antigen Detection.
LMA036Bo Multiplex Assay Kit for Fibroblast Growth Factor 9 (FGF9) ,etc. by FLIA (Flow Luminescence Immunoassay) FLIA Kit for Antigen Detection.